Home > > > Blood Transfusion Diagnostics Market to Exceed USD 7.7 Billion by 2034, Growing at a CAGR of 4.9%

Blood Transfusion Diagnostics Market to Exceed USD 7.7 Billion by 2034, Growing at a CAGR of 4.9%

Author : kaustubh Ravan | Published On : 25 Mar 2026

The global blood transfusion diagnostics market was valued at USD 4.6 billion in 2023 and is projected to exceed USD 7.7 billion by 2034. The industry is expected to grow at a CAGR of 4.9% from 2024 to 2034, driven by increasing demand for safe blood screening, rising prevalence of chronic diseases, and advancements in diagnostic technologies.

Transform Your Strategy: Explore In-Depth Data – Sample Available! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85892

Market dynamics are defined by a rigorous shift toward absolute transfusion safety. Regulatory bodies worldwide are mandating zero-tolerance policies for Transfusion-Transmissible Infections (TTIs) like HIV, Hepatitis B, and Syphilis, forcing blood banks to transition from manual serological tests to high-sensitivity Molecular Nucleic Acid Testing (NAT). Despite the high capital expenditure required for advanced diagnostic platforms, the move toward automation is viewed as a necessary investment to eliminate human error and optimize laboratory workflows in high-volume settings.

Technological innovation is currently centered on the "Smart Laboratory" concept. Key players are launching integrated analyzers that combine AI-based 3D reconstruction for blood drawing with robotic needle insertion to ensure consistent sample collection. Furthermore, the development of multiplex detection platforms allows for the simultaneous screening of multiple pathogens from a single donor sample, significantly reducing turnaround times. Innovations such as "autonomous blood collection" and AI-driven predictive modeling for transfusion needs are transitioning from pilot phases to clinical implementation, enhancing real-time inventory management.

Next-generation diagnostics are moving toward localized, "point-of-transfusion" testing. Manufacturers are engineering compact, portable blood typing workstations and rapid test kits designed for resource-limited environments and emergency trauma care. As the industry advances toward 2032, the focus is expanding beyond traditional grouping to include precise blood group genotyping, which allows for better matching of rare blood types and reduces the risk of alloimmunization in patients receiving chronic transfusion therapy.

Key Findings of the Market Report

  • Based on product, the Reagents & Kits segment dominated the market, accounting for approximately 79% of revenue in 2026 due to recurring sales for routine screening.
  • The Disease Screening application held a dominant share of roughly 45% in 2024, driven by mandatory pathogen testing protocols globally.
  • Serology-based Testing remains the leading technology segment (48.6% share), though Molecular Testing is projected to witness the highest growth rate through 2034.
  • North America remains the largest market (approx. 40% share), while Asia-Pacific is the fastest-growing region, fueled by rapid healthcare infrastructure development in China and India.

Global Blood Transfusion Diagnostics Market: Growth Drivers

  • Rising Burden of Blood Disorders: Increasing global incidence of hematological conditions such as thalassemia, hemophilia, and sickle cell disease.
  • Advancements in Automation: Integration of AI and robotics in laboratory workflows to enhance diagnostic precision and operational efficiency.
  • Increasing Surgical Volume: A surge in trauma cases, organ transplants, and elective surgeries that necessitate robust pre-transfusion compatibility testing.
  • Government Blood Safety Initiatives: Stringent national policies for blood donor screening and increased funding for public blood donation campaigns.

Global Blood Transfusion Diagnostics Market: Regional Landscape

  • North America leads the market, supported by advanced diagnostic centers, high healthcare expenditure, and the presence of major industry players like Abbott and Bio-Rad.
  • Europe demonstrates strong growth with a focus on standardization and high-quality control under the new IVDR (In Vitro Diagnostic Regulation) framework.
  • Asia-Pacific is the high-growth engine, characterized by rising medical tourism, improving healthcare accessibility, and government-led modernization of blood bank facilities.

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights: https://www.transparencymarketresearch.com/checkout.php?rep_id=85892&ltype=S

Global Blood Transfusion Diagnostics Market: Key Players

Leading companies are focusing on the launch of high-throughput molecular platforms and AI-enabled software to provide end-to-end transfusion management.

  • Roche Diagnostics (Switzerland)
  • Grifols, S.A. (Spain)
  • Immucor, Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Abbott Laboratories (U.S.)
  • Ortho Clinical Diagnostics (QuidelOrtho)
  • Siemens Healthineers (Germany)
  • Fresenius Kabi AG (Germany)
  • bioMérieux SA (France)
  • Terumo Corporation (Japan)

Global Blood Transfusion Diagnostics Market: Segmentation

By Product

  • Reagents & Kits (Antisera, Control Solutions, enzymes)
  • Instruments (Blood Typing Analyzers, Automated Processing Systems)
  • Software Solutions & Consumables

By Technology

  • Serology-based Testing (ELISA, CLIA)
  • Molecular-based Testing (NAT, NGS, PCR)
  • Western Blot & Rapid Tests

By Application

  • Blood Screening (Infectious Diseases)
  • Blood Group Typing (ABO/Rh & Cross-matching)
  • Research & Precision Immunohematology

By End-User

  • Hospitals & Hospital-based Laboratories
  • Independent Diagnostic Laboratories
  • Blood Banks
  • Plasma Fractionation Companies

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com 
Sales Inquiries: [email protected]
Media Inquiries: [email protected]